2022: Q&A with hVIVO CEO, Mo Khan
Jan 21 2025
Length: 7 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

2022: Q&A with hVIVO CEO, Mo Khan

Listen for free

View show details

Summary
Watch on YouTube

hVIVO has secured a £2.7 million contract for its hLAB division to serve as the sole virology lab for a global Phase 2 influenza drug study involving 5,000 participants. This milestone marks hVIVO's largest standalone lab services contract, leveraging its expanded Canary Wharf facility.

Show more Show less

Show more Show less

What listeners say about 2022: Q&A with hVIVO CEO, Mo Khan

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon